164
Helvetica Chimica Acta Vol. 87 (2004)
(40 ml) containing conc. H2SO4 (0.7 ml). The mixture was refluxed overnight. After cooling in a refrigerator,
crystals separated and were collected to afford 7 (4.5 g, 41% over two steps). M.p. 149 1518 (lit. 154.58 [29]). IR
1
(KBr): 3080, 1747, 1442, 1365, 1280, 1242, 1163, 999, 757, 719, 690. H-NMR (250 MHz, CDCl3): 8.81 (s, 2 H);
4.07 (s, 6 H); 4.05 (s, 3 H). 13C-NMR (50 MHz, CDCl3): 164.2; 163.7; 149.2; 140.1; 126.3; 53.2; 53.1. Anal. calc.
for C11H11NO6 (253.21): C 52.18, H 4.38, N 5.33; found: C 51.94, H 4.38, N 5.09.
General Procedures for the Synthesis of Macrocyclic Amides. Method A: An equimolar 0.1m soln. of a,w-
diamine and dimethyl dicarboxylate in anh. MeOH was left at ambient temp. over a period of at least 7 d. The
solvent was evaporated, and the residue was purified by CC (SiO2; CH2Cl2 with 0.5 10% MeOH).
Method B: Na Metal (2.30 g, 100 mmol) was added to anh. MeOH (100 ml). Then, the mixture was cooled
to 58, and the a,w-diamine (10 mmol) and dimethyl dicarboxylate (10 mmol) were added. This mixture was left
at ambient temp. over a period of at least 12 h. The solvent was evaporated, and the residue was purified by CC
(SiO2; CH2Cl2 with 0.5 10% MeOH).
3,12-Dimethyl-6,9-dioxa-3,12,18-triazabicyclo[12.3.1]octadeca-1(17),14(18),15-triene-2,13-dione (4). Meth-
od A: 2.7%. Method B: 4.0%. M.p. 186 1898. 1H-NMR (200 MHz, CDCl3): 8.18 (d, J 7.3, 2 H); 8.09 7.87
(m, 1 H); 3.90 3.38 (m, 12 H); 3.19 (s, 6 H). 13C-NMR (50 MHz, CDCl3): 162.3; 148.0; 139.4; 124.0; 70.6;
69.10; 47.2; 38.8. HR-MS: 307.1528 (M , C15H2N3O4 ; calc.: 307.1532).
3,6,14,17-Tetramethyl-3,6,14,17,23,24-hexaazatricyclo[17.3.1.18,12]tetracosa-1(23),8,10,12(24),19,21-hexaene-
2,7,13,18-tetraone (5). Method A: 10.1%. Colorless crystals. M.p. 245 2498. IR (KBr): 3436, 3010, 2924, 1636,
1501, 1418, 1353, 1315, 1076, 840, 759, 645. 1H-NMR (200 MHz, CDCl3): 7.9 8.1 (m, 2 H); 7.8 7.9 (m, 4 H);
4.2 4.4 (m, 4 H); 3.6 3.8 (m, 4 H); 3.22 (s, 12 H). 13C-NMR (50 MHz, CDCl3): 168.2; 152.4; 138.5; 125.4; 47.7;
41.7. EI-MS: 438 (50.5, M ), 410 (20.3), 367 (23.0), 354 (44.8), 190 (22.5), 176 (20.0), 163 (32.6), 162 (38.9), 161
(65.7), 149 (45.4), 148 (100), 106 (30.5), 105 (31.4), 78 (30.9), 77 (33.8). Anal. calc. for C22H26N6O4 (438.48):
C 60.26, H 5.98, N 19.17; found: C 59.98, H 6.10, N 18.97.
15,16-Dimethoxy-6,9,17-trioxa-3,12-diazabicyclo[12.2.1]heptadeca-1(16),14-diene-2,13-dione (11). Meth-
od B: 36%. Colorless crystals. M.p. 182 1838. IR (KBr): 3436, 2905, 1667, 1570, 1525, 1341, 1206, 1101, 841,
609, 565. 1H-NMR (500 MHz, CDCl3): 7.23 (br. s, 2 H); 4.19 (s, 6 H); 3.71 (s, 2 H); 3.6 3.7 (m, 2 H); 3.56
(q, J 5.0, 2 H). 13C-NMR (125 MHz, CDCl3): 157.2; 144.3; 128.9; 70.8; 68.6; 62.4; 38.4; 29.7. EI-MS: 328 (100,
M ), 196 (38), 182 (32), 168 (40), 154 (34), 83 (29.0). HR-LSI-MS: 328.1293 (M , C14H20N2O7 ; calc.:
328.1271). Anal. calc. for C14H20N2O7 (328.32): C 51.22, H 6.14, N 8.53; found: C 51.31, H 6.38, N 8.70.
Methyl 2,13-Dioxo-6,9-dioxa-3,12,18-triazabicyclo[12.3.1]octadeca-1(18),14,16-triene-16-carboxylate (13).
Method A: 83%. Colorless crystals. M.p. 241 2438. IR (KBr): 3401, 3386, 2909, 2882, 1735, 1691, 1530, 1451,
1264, 1241, 1117, 1097, 653. 1H-NMR (200 MHz, CDCl3): 8.8 8.9 (m, 4 H); 4.02 (s, 3 H); 3.6 3.8 (m, 12 H).
13C-NMR (50 MHz, CDCl3): 164.4; 161.8; 149.4; 141.3; 123.3; 70.6; 68.4; 53.0; 38.9. HR-MS: 337.1264 (M ,
C15H19N3O6 ; calc.: 337.1274). Anal. calc. for C15H19N3O6 (337.33): C 53.41, H 5.68, N 12.46; found: C 53.51,
H 5.58, N 12.50.
6,9-Dioxa-3,12,15,17-tetraazabicyclo[12.3.1]octadeca-1(18),14,16-triene-2,13-dione (15). Method A: 2%.
Method B: 2%. Colorless crystals. M.p. 183 1848. 1H-NMR (500 MHz, CDCl3): 9.22 (d, J 1.3, 1 H); 8.68
(d, J 1.3, 1 H); 8.30 (br. t, J 5.5, 2 H); 3.6 3.8 (m, 12 H). 13C-NMR (125 MHz, CDCl3): 162.0; 156.9; 115.7;
70.3; 69.4; 39.5. HR-LSI-MS: 281.1243 ([M H] , C12H17N4O4 ; calc.: 281.1250).
6,9-Dioxa-3,12,18-triazabicyclo[12.3.1]octadeca-1(18),14,16-triene-2,13-dione 18-Oxide (20). Method A:
4%. Method B: 67%. Colorless crystals. M.p. 241 2438. IR (KBr): 3173, 2913, 2879, 1696, 1683, 1560, 1386,
1097. 1H-NMR (400 MHz, CDCl3): 11.60 (br. s, 2 H); 8.32 (d, J 7.9, 2 H); 7.57 (t, J 7.9, 1 H); 3.5 3.7
(m, 12 H). 13C-NMR (100 MHz, CDCl3): 158.7; 143.2; 128.7; 127.5; 71.1; 68.6; 39.4. HR-ESI-MS: 318.1076
([M Na] , C13H17N3O5Na ; calc.: 318.1060). Anal. calc. for C13H17N3O5 (295.29): C 52.88, H 5.80, N 14.23;
found: C 52.64, H 5.79, N 14.12.
6,9,23,26-Tetraoxa-3,12,15,17,20,29,32,34-octaazatricyclo[29.3.1.114,18]hexatriaconta-
1(35),14,16,18(36),31,33-hexaene-2,13,19,30-tetraone (16). Method A: 6%. Method B: 6%. Colorless crystals.
M.p. 216 2188. IR (KBr): 3333, 2939, 1694, 1518, 1423, 1269, 1141, 1102, 1077, 665. 1H-NMR (200 MHz,
CF3COOD): 9.30 (s, 2 H); 8.93 (s, 2 H); 3.6 4.2 (m, 24 H). 13C-NMR (50 MHz, CF3COOD): 160.5; 158.7;
119.0; 98.1; 72.1; 71.4; 42.1. HR-LSI-MS: 561.2417 ([M H] , C24H33O8N8 ; calc.: 561.2421). Anal. calc. for
C24H32N8O8 ¥ 2 H2O (596.59): C 48.32, H 6.08, N 18.78; found: C 48.00, H 6.25, N 18.87.
6,9,23,26-Tetraoxa-3,12,20,29,35,36-hexaazatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-
hexaene-2,13,19,30-tetraone 35,36-Dioxide (21). Method A: 32%. Method B: 26%. Colorless crystals. M.p. 234
2448. IR (KBr): 3436, 3221, 2925, 2875, 1681, 1535, 1518, 1390, 1116. H-NMR (400 MHz, CDCl3): 10.88 (br. s,
2 H); 8.53 (d, J 8.0, 2 H); 7.58 (t, J 8.0, 1 H); 3.6 3.8 (m, 12 H). 13C-NMR (100 MHz, CDCl3): 159.4; 141.4;
1